Andere Sprachen Shenzhen YHLO Biotech Co., Ltd.

Aktien

688575

CNE100005204

688575

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 11.06.2024			% 5 Tage	% 1. Jan.
25,46 ^CNY	+1,43 %		+1,07 %	+11,32 %

19.04.	Shenzhen YHLO Biotech Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
23.02.	Shenzhen YHLO Biotech Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.	17.05.
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19.04.
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23.02.
YHLO Biotech Secures US FDA Clearance for Two In-Vitro Diagnostics Products	13.12.
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Shenzhen YHLO Biotech Co., Ltd.(XSSC:688575) added to S&P Global BMI Index	18.09.23
YHLO Biotech Registers Reagent For Detecting Heart Failure	15.09.23
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17.08.23
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2023.	17.05.23
YHLO Biotech Unit Gets Certification for Two Medical Devices	10.05.23
YHLO Biotech Unit Registers New Medical Device	04.05.23
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28.04.23
YHLO Biotech Gets Registration Certificate for Automatic Biochemical Analyzer	05.04.23
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27.02.23
YHLO Biotech Gets Registration Certificate for Anti-Desmoglein 3 Antibody Detection Kit	03.02.23
YHLO Biotech's COVID-19 Antigen Kit Added to WHO's Emergency Use List	04.11.22
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28.10.22
Longlight announced that it has received $1.380000 million in funding from Shenzhen YHLO Biotech Co., Ltd., Yanghe Capital Holding Group Limited and other investors.	25.10.22
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	20.07.22
Shenzhen YHLO Biotech Co., Ltd.(SHSE:688575) added to Shanghai Stock Exchange A Share Index	17.05.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Shenzhen YHLO Biotech Co., Ltd.

Aktien

688575

CNE100005204

688575

Andere Sprachen

Filter